Incyte (INCY) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90% |
| Dec 31, 2025 | 5.48% |
| Sep 30, 2025 | 9.89% |
| Jun 30, 2025 | 11.97% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | 15.12% |
| Jun 30, 2024 | 17.58% |
| Mar 31, 2024 | 16.30% |
| Dec 31, 2023 | 18.64% |
| Sep 30, 2023 | 19.50% |
| Jun 30, 2023 | 22.87% |
| Mar 31, 2023 | 22.89% |
| Dec 31, 2022 | 23.27% |
| Sep 30, 2022 | 23.73% |
| Jun 30, 2022 | 26.94% |
| Mar 31, 2022 | 30.43% |
| Dec 31, 2021 | 33.98% |
| Sep 30, 2021 | 35.21% |
| Jun 30, 2021 | 36.71% |
| Mar 31, 2021 | 45.05% |
| Dec 31, 2020 | 45.44% |
| Sep 30, 2020 | 43.05% |
| Jun 30, 2020 | 40.94% |
| Mar 31, 2020 | 38.43% |
| Dec 31, 2019 | 35.79% |
| Jun 30, 2019 | 43.56% |
| Mar 31, 2019 | 54.32% |
| Dec 31, 2018 | 64.13% |
| Sep 30, 2018 | 117.35% |
| Jun 30, 2018 | 112.09% |
| Mar 31, 2018 | 109.96% |
| Dec 31, 2017 | 110.08% |
| Sep 30, 2017 | 109.14% |
| Jun 30, 2017 | 101.96% |
| Mar 31, 2017 | 98.74% |
| Dec 31, 2016 | 91.97% |
| Sep 30, 2016 | 90.37% |
| Jun 30, 2016 | 90.65% |
| Mar 31, 2016 | 79.76% |
| Dec 31, 2015 | 78.07% |